 and recommendations for the management of perioperative MI risk after CEA.
1. Perioperative MI after CEA is best avoided by appropriate preoperative treatment of relevant atherosclerotic risk factors, screening for coronary artery
disease when appropriate, and standard pharmacologic management of atherosclerosis during the perioperative period.
2. All patients undergoing CEA should be treated with a
statin medication, unless a contraindication exists.
3. All patients undergoing CEA should be